FDA Guidance on Diversity Plans in Clinical Trials: What You Need to Know | Bass, Berry & Sims PLC
[ad_1] The United States Food and Drug Administration (FDA) issued draft guidance on April 13, 2022, entitled, โDiversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations […]






















